|
시장보고서
상품코드
2051343
심장 인공 보철 장치 시장 : 제품 유형별Cardiac Prosthetic Devices Market, By Product Type |
||||||
심장 인공 보철 장치 시장은 2026년에 98억 1,000만 달러로 추정되며, 2033년까지 185억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.5%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 98억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.50% | 2033년 시장 규모 예측 : | 185억 2,000만 달러 |
심장 인공 보철 장치에는 기계식 및 조직 유래 인공심장판막, 판막형성 링, 심박조율기 및 제세동기 리드, 조직 패치, 인공심장, 심실보조장치 등이 포함됩니다. 이들은 손상되거나 병변이 생긴 심장의 원래 판막을 대체하는 데 사용됩니다. 예측 기간 동안 고혈압 증가는 세계 인공심장 의료기기 시장의 성장을 견인할 것으로 예측됩니다. 또한, 조사의 진전과 신제품의 도입으로 시장은 더욱 확대될 것으로 예측됩니다.
시장 역학
주요 시장 기업들은 제품 포트폴리오와 시장에서의 지리적 입지를 강화하기 위해 제품 출시, 제휴 등 다양한 성장 전략을 채택하는 데 주력하고 있으며, 이는 예측 기간 동안 세계 인공심장 의료기기 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2023년 6월 8일, 의료기기 제조업체인 애보트(Abbott)는 경피적 카테터 판막연결술(TEER) 장치인 'MitraClip'과 세계 최초의 저침습적 삼첨판막 수리 장치인 'TriClip'에 대한 결과 데이터를 발표하였습니다. 이 데이터는 승모판막 역류(MR) 및 삼첨판막 역류(TR)에 대한 구조적 심장 솔루션의 효능을 입증하는 것으로, 심장 판막 역류로 고통받는 다양한 환자군을 대상으로 합니다.
마찬가지로, 2022년 10월, 의료기기 제조업체인 셀릭스 메디컬(Celix Medical)은 의료기기 제조업체인 오시프카 메디컬(Osipka Medical)과 제휴하여 심부전 및 기타 심장 질환 환자를 위한 심장 박동기 장치를 개발한다고 발표했습니다.
또한, 2022년 2월에는 의료기기 제조업체인 Abbott가 AVEIR DR i2i 주요 임상시험의 일환으로 듀얼 챔버 리드 리스폰스 제조업체 시스템을 환자에게 이식하기 시작했다고 발표했습니다. Abbott의 임상시험용 Aveir 듀얼 챔버 무균실 임베디드 무균실은 최첨단 무균실 기술을 구현한 제품입니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서에서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 기반으로 세계 심장 인공장기 장치 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- '세계 심장 인공장기 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 심장 인공장기 장치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 심장 인공 보철 장치 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 심장 인공 보철 장치 시장 : 최종사용자별, 2021년-2033년
제6장 세계의 심장 인공 보철 장치 시장 : 지역별, 2021년-2033년
제7장 경쟁 구도
제8장 섹션
LSH 26.06.18Cardiac Prosthetic Devices Market is estimated to be valued at USD 9.81 Bn in 2026 and is expected to reach USD 18.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.81 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.50% | 2033 Value Projection: | USD 18.52 Bn |
Cardiac prosthetic devices include mechanical and tissue prosthetic heart valves, annuloplasty rings, pacemaker and defibrillator leads, tissue patches, artificial hearts, and ventricular assist devices. These are used to replace the heart's native valves that have been harmed or become ill. Over the forecast period, rising levels of hypertension are anticipated to fuel market expansion for cardiac prosthetic devices worldwide. The market is also expected to rise as a result of increased research and product introductions.
Market Dynamics
The key market players are focused on adopting various growth strategies such as product launches, partnerships, and others to strengthen their product portfolio and geographical presence in the market, which in turn is expected to drive the growth of the global cardiac prosthetics devices market over the forecast period. For instance, on June 8, 2023, Abbott, a medical device company, announced result data for MitraClip, which is a transcatheter edge-to-edge repair (TEER) device, and TriClip, a first-of-its-kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves.
Similarly, in October 2022, Ceryx Medical, a medical device company, in partnership with Osypka Medical, a medical device company, announced the development of a heart-pacing device for patients with heart failure and other cardiac conditions
Furthermore, in February 2022, Abbott, a medical device company, announced the launch of patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker represents technological leadless pacing technology.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiac prosthetics devices market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, Artivion, Inc., Medtronic, Boston Scientific Corporation, Edwards Lifesciences Corporation., Siemens Healthcare Private Limited, LivaNova PLC (sorin group), Asahi Kasei Corporation., OSYPKA MEDICAL, Lepu Medical, MicroPort Scientific Corporation., Vitatron, Koninklijke Philips N.V., Progetti srl and Shree Pacetronix Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Cardiac Prosthetics Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac prosthetics devices market.
Market Segmentation
- Global Cardiac Prosthetic Devices Market, By Product Type (Revenue, USD Bn, 2021 - 2033):
- Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Implantable pacemakers
- Global Cardiac Prosthetic Devices Market, By End user (Revenue, USD Bn, 2021 - 2033):
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others (Academic & Research Institutes and Others)
- Global Cardiac Prosthetic Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbott.
- Artivion, Inc.
- Medtronic
- Boston Scientific Corporation
- Edwards Lifesciences Corporation.
- Siemens Healthcare Private Limited
- LivaNova PLC (Sorin Group)
- Asahi Kasei Corporation.
- OSYPKA MEDICAL
- Lepu Medical
- MicroPort Scientific Corporation.
- Vitatron
- Koninklijke Philips N.V.,
- Progetti srl
- Shree Pacetronix Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End user
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Overview on all types of heart valve and pacemakers
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective on growth and demand of Cardiac Prosthetics Devices
- Top Market Players by Revenue
4. Global Cardiac Prosthetic Devices Market, By Product Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Heart Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Mechanical Heart Valves
- Tissue Heart Valves
- Stented tissue valve
- Stentless tissue valve
- Transcatheter Heart Valves
- Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemaker
- Implantable pacemakers
5. Global Cardiac Prosthetic Devices Market, By End user, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others (Academic & Research Institutes and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Cardiac Prosthetic Devices Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Edwards Lifesciences Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova PLC (Sorin Group)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Asahi Kasei Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OSYPKA MEDICAL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lepu Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vitatron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Progetti srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shree Pacetronix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
